The Myeloma Patient Outcome Scale is the first quality of life tool developed for clinical use and validated in patients with follicular lymphoma.

Joanna M DaviesThomas R OsbornePolly M EdmondsSteve A ScheySteve DevereuxIrene J HigginsonChristina Ramsenthaler

Published in: European journal of haematology (2017)

The MyPOS is valid, reliable and acceptable, and can be used to support clinical care of FL patients. This is the first measurement tool developed specially for use in clinical practice that has been validated for use in people with FL. Further longitudinal validation is now required to support its use in outcome measurement.

Keyphrases

newly diagnosed
end stage renal disease
clinical practice
healthcare
chronic kidney disease
ejection fraction
case report
cross sectional
patient reported outcomes
affordable care act